Chronic Coccygodynia and ganglion impar block: How does contrast material distribution affect treatment outcomes?
Saved in:
| Title: | Chronic Coccygodynia and ganglion impar block: How does contrast material distribution affect treatment outcomes? |
|---|---|
| Authors: | Olgun, Yucel, Sencan, Savas, Unver, Sena, Osmanli, Nuride, Kokar, Serdar, Gunduz, Osman Hakan |
| Source: | Pain Practice. Apr2025, Vol. 25 Issue 4, p1-7. 7p. |
| Subjects: | Academic medical centers, T-test (Statistics), Fisher exact test, Probability theory, Treatment effectiveness, Retrospective studies, Chi-squared test, Mann Whitney U Test, Descriptive statistics, Ganglionic blocking agents, Medical records, Acquisition of data, Data analysis software, Coccydynia, Nerve block, Contrast media, Fluoroscopy |
| Abstract: | Aim: To assess the influence of contrast material distribution patterns on treatment success in patients with chronic coccygodynia undergoing ganglion impar block (GIB). Methods: An evaluation was conducted on 58 patients who underwent GIB from August 2021 to August 2023 at a university hospital's interventional pain management center. Numeric rating scale (NRS) scores were recorded before the procedure and at 1‐month post‐procedure. The patients were categorized into two groups based on treatment success, defined as at least a 50% reduction in the NRS score at 1 month. Results: There were no significant differences between the two groups regarding age, gender, BMI, symptom duration, comorbidities, coccyx curvature type, presence of anterior/posterior subluxation, presence of posterior spicule, type of approach, contrast distribution direction, and contrast dye level. Patients with coccygodynia experienced statistically significant benefits from GIB treatment at the 1‐month follow‐up (p < 0.001). Conclusion: Although the use of contrast material in fluoroscopic procedures is the gold standard to prevent possible complications, the distribution pattern of contrast does not significantly affect the success of GIB treatment in patients with coccygodynia. Further prospective and long‐term follow‐up studies are required to validate these findings. [ABSTRACT FROM AUTHOR] |
| Copyright of Pain Practice is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Aim: To assess the influence of contrast material distribution patterns on treatment success in patients with chronic coccygodynia undergoing ganglion impar block (GIB). Methods: An evaluation was conducted on 58 patients who underwent GIB from August 2021 to August 2023 at a university hospital's interventional pain management center. Numeric rating scale (NRS) scores were recorded before the procedure and at 1‐month post‐procedure. The patients were categorized into two groups based on treatment success, defined as at least a 50% reduction in the NRS score at 1 month. Results: There were no significant differences between the two groups regarding age, gender, BMI, symptom duration, comorbidities, coccyx curvature type, presence of anterior/posterior subluxation, presence of posterior spicule, type of approach, contrast distribution direction, and contrast dye level. Patients with coccygodynia experienced statistically significant benefits from GIB treatment at the 1‐month follow‐up (p < 0.001). Conclusion: Although the use of contrast material in fluoroscopic procedures is the gold standard to prevent possible complications, the distribution pattern of contrast does not significantly affect the success of GIB treatment in patients with coccygodynia. Further prospective and long‐term follow‐up studies are required to validate these findings. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 15307085 |
| DOI: | 10.1111/papr.70024 |
